Blood thinner to prevent stroke after stress-related irregular heartbeats
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had at least one important episode of atrial fibrillation that happened during a recent stressor within the last 35 days
- That atrial fibrillation had stopped and your heart rhythm is normal (sinus rhythm) right before study assignment
- You’re in a higher-stroke-risk group (based on age and other heart or blood-vessel risks)
- You can sign written consent and agree to follow study instructions and follow-up
- You do not have a reason that makes long-term blood thinners unsafe (for example, certain bleeding problems, major recent stroke, or very poor kidney/liver function)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This trial tests how well blood thinners (anticoagulants) work to dissolve clots in the heart of people with atrial fibrillation (an irregular heartbeat). It aims to find the best treatment for these clots before more serious complications occur.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This trial looks at ways to help people with atrial fibrillation lower their risk of stroke, premature death, and worsening memory. It may help by identifying which prevention approach works best for a broader community of patients.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.